Orange Book product · Brand (NDA)
SEEBRI NEOHALER
GLYCOPYRROLATE
At a glance
Oct 29, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 29, 2015
10 yr 10 mo ago
Today
Patent 8479730 expires
Listed drug product patent expiration.
Oct 11, 2028
in 2 yr 4 mo
Patent 8182838 expires
Listed drug product patent expiration.
Oct 20, 2028
in 2 yr 4 mo
Pharmaceutical detail
Active ingredient
GLYCOPYRROLATE
Strength
15.6MCG/INH
Dosage form
POWDER
Route
INHALATION
TE code
Not listed
Application
NDA 207923
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023DARTISLA ODTBrand (NDA)
NDA 215019 · EDENBRIDGE PHARMS
- 2022GLYCOPYRROLATEBrand (NDA)
NDA 214919 · FRESENIUS KABI USA
- 2018GLYRX-PFBrand (NDA)
NDA 210997 · EXELA PHARMA
- 2017LONHALA MAGNAIR KITBrand (NDA)
NDA 208437 · SUMITOMO PHARMA AM
- 2010CUVPOSABrand (NDA)
NDA 022571 · MERZ PHARMS
- —ROBINULBrand (NDA)
NDA 017558 · HIKMA
- —ROBINULBrand (NDA)
NDA 014764 · ROBINS AH
- 2026GLYCOPYRROLATEGeneric (ANDA)
ANDA 216910 · QUAGEN
- 2025GLYCOPYRROLATEGeneric (ANDA)
ANDA 220062 · BIONPHARMA
- 2025GLYCOPYRROLATEGeneric (ANDA)
ANDA 219267 · AJENAT PHARMS
- 2025GLYCOPYRROLATEGeneric (ANDA)
ANDA 216084 · MSN
- 2024GLYCOPYRROLATEGeneric (ANDA)
ANDA 214847 · AUROBINDO PHARMA LTD
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8479730 | Oct 11, 2028 | in 2 yr 4 mo | Product |
| 8182838 | Oct 20, 2028 | in 2 yr 4 mo | Product |

